Latest news
Tenax Therapeutics (TENX) Shares Collapse 89% After Phase 3 Tria - GuruFocusGuruFocus · Mon, 10 Aug 2026 15:14:57 GMTTenax Therapeutics Phase 3 LEVEL Trial Misses Primary Endpoint for TNX-103 - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 15:03:31 GMTTenax Therapeutics (TENX) Stock Plummets 87% Amid Clinical Setba - GuruFocusGuruFocus · Mon, 10 Aug 2026 14:16:20 GMTTENX Stock Whipsaws As Traders Eye Volatility And Cash Pile - StocksToTradeStocksToTrade · Mon, 10 Aug 2026 13:17:00 GMTTenax Therapeutics (NASDAQ:TENX) Drops 85% as Phase 3 LEVEL Study Fails to Meet Main Endpoints - TechStock²TechStock² · Mon, 10 Aug 2026 12:46:29 GMTTenax Therapeutics (TENX) Reports Phase 3 LEVEL Trial Results, F - GuruFocusGuruFocus · Mon, 10 Aug 2026 12:19:57 GMTTenax Therapeutics Stock Plummets 84% After Phase 3 Trial Failure - StockInvest.usStockInvest.us · Mon, 10 Aug 2026 12:13:05 GMTTenax Therapeutics reports Phase 3 LEVEL topline: missed primary but strong biomarker and subgroup signals - TradingViewTradingView · Mon, 10 Aug 2026 11:23:01 GMT